As oral semaglutide and higher dulaglutide doses are recent to the market, additional real-world evidence is required to evaluate utilization patterns
Most of it splashes everywhere before getting through
00:00:57 Narrator With that, Lets get started 00:01:05 Vickie Danaher We know that the injectable GLP-1 medications have become pretty popular over the last few years for obesity, type 2 diabetes, and other conditions, but the fact that we now have an oral GLP-1 agonist for weight loss is a big change
Cherpes TL, Meyn LA, Krohn MA, Hillier SL
While there's no single right way to taper, gradually reducing your dose with the guidance of your provider may help you avoid rapid weight regain and keep other benefits
Fatigue Some patients report feeling unusually tired during the first few weeks of tirzepatide use